Canadian Neurosurgeons Seek Participants for Musk’s Neuralink Brain Study
TORONTO, Nov 22 (Reuters) – Canadian neurosurgeons, in collaboration with Elon Musk’s Neuralink, have received regulatory approval to recruit six patients with paralysis for a groundbreaking brain study. The trial, named CAN-PRIME, aims to test the safety and effectiveness of a Neuralink device that enables users to control cursors with their thoughts. Each participant will undergo a procedure involving the implantation of a device with 1,000 electrode contacts in their brain.
Share this content:
Post Comment